Circulation Research, Vol 68, 1610-1613, Copyright © 1991 by American Heart Association
ARTICLES |
PE Ganey, LS Carter, RA Mueller and RG Thurman
Laboratory of Hepatobiology and Toxicology, University of North Carolina, Chapel Hill 27599-7365.
The purpose of these studies was to test whether O2 tension influences cardiotoxicity due to doxorubicin. Isolated hearts were perfused by the method of Langendorff at constant pressure with Krebs-Henseleit buffer saturated with 5% CO2 and either 95% or 20% O2. Toxicity due to doxorubicin was evaluated from changes in heart rate and from uptake of trypan blue by nonviable nuclei. Heart rate was stable in control hearts perfused at 95% O2 for 30 minutes but decreased in hearts perfused at 20% O2. Doxorubicin (30 microM) increased O2 uptake due to redox cycling by approximately 75 mumol/g/hr at 95% O2 but had no effect in hearts perfused at 20% O2. Heart rate decreased during 30 minutes of perfusion with doxorubicin and 95% or 20% O2, with greater decreases occurring with 95% than 20% O2 compared with values for the respective untreated controls. Irreversible cell damage indexed from uptake of vital dye due to doxorubicin was threefold greater than control at 95% O2 but was not different from control at at 20% O2. These data are consistent with the hypothesis that O2 tension is an important determinant of toxicity due to doxorubicin.
This article has been cited by other articles:
![]() |
G.-C. Fan, X. Zhou, X. Wang, G. Song, J. Qian, P. Nicolaou, G. Chen, X. Ren, and E. G. Kranias Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity Circ. Res., November 21, 2008; 103(11): 1270 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, Z. Chen, C. C. Chua, Y.-S. Ma, G. A. Youngberg, R. Hamdy, and B. H. L. Chua Melatonin as an effective protector against doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H254 - H263. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cardinale, M. T. Sandri, A. Martinoni, A. Tricca LabTech, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. M. Cipolla, and C. Fiorentini Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy J. Am. Coll. Cardiol., August 1, 2000; 36(2): 517 - 522. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |